These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8646743)

  • 1. Amplification of 19q13.1-q13.2 sequences in ovarian cancer. G-band, FISH, and molecular studies.
    Thompson FH; Nelson MA; Trent JM; Guan XY; Liu Y; Yang JM; Emerson J; Adair L; Wymer J; Balfour C; Massey K; Weinstein R; Alberts DS; Taetle R
    Cancer Genet Cytogenet; 1996 Mar; 87(1):55-62. PubMed ID: 8646743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of a candidate oncogene SEI-1 within a minimal amplified region at 19q13.1 in ovarian cancer cell lines.
    Tang TC; Sham JS; Xie D; Fang Y; Huo KK; Wu QL; Guan XY
    Cancer Res; 2002 Dec; 62(24):7157-61. PubMed ID: 12499249
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas.
    Cheng JQ; Godwin AK; Bellacosa A; Taguchi T; Franke TF; Hamilton TC; Tsichlis PN; Testa JR
    Proc Natl Acad Sci U S A; 1992 Oct; 89(19):9267-71. PubMed ID: 1409633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isolation of DNA sequences amplified at chromosome 19q13.1-q13.2 including the AKT2 locus in human pancreatic cancer.
    Miwa W; Yasuda J; Murakami Y; Yashima K; Sugano K; Sekine T; Kono A; Egawa S; Yamaguchi K; Hayashizaki Y; Sekiya T
    Biochem Biophys Res Commun; 1996 Aug; 225(3):968-74. PubMed ID: 8780719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplification of C-MYC as the origin of the homogeneous staining region in ovarian carcinoma detected by micro-FISH.
    Abeysinghe HR; Cedrone E; Tyan T; Xu J; Wang N
    Cancer Genet Cytogenet; 1999 Oct; 114(2):136-43. PubMed ID: 10549271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas.
    Bellacosa A; de Feo D; Godwin AK; Bell DW; Cheng JQ; Altomare DA; Wan M; Dubeau L; Scambia G; Masciullo V; Ferrandina G; Benedetti Panici P; Mancuso S; Neri G; Testa JR
    Int J Cancer; 1995 Aug; 64(4):280-5. PubMed ID: 7657393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amplification of DNA sequences from chromosome 19q13.1 in human pancreatic cell lines.
    Curtis LJ; Li Y; Gerbault-Seureau M; Kuick R; Dutrillaux AM; Goubin G; Fawcett J; Cram S; Dutrillaux B; Hanash S; Muleris M
    Genomics; 1998 Oct; 53(1):42-55. PubMed ID: 9787076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of homogeneously staining regions in non-Hodgkin lymphomas.
    Arranz E; Robledo M; Martínez B; Gallego J; Román A; Rivas C; Benítez J
    Cancer Genet Cytogenet; 1996 Mar; 87(1):1-3. PubMed ID: 8646732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of 11q13 amplification as the origin of a homogeneously staining region in small cell lung cancer by chromosome microdissection.
    Xu J; Tyan T; Cedrone E; Savaraj N; Wang N
    Genes Chromosomes Cancer; 1996 Nov; 17(3):172-8. PubMed ID: 8946196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorescence in situ hybridization analysis using cosmid probes to define chromosome 6q abnormalities in ovarian carcinoma cell lines.
    Lastowska MA; Lillington DM; Shelling AN; Cooke I; Gibbons B; Young BD; Ganesan TS
    Cancer Genet Cytogenet; 1994 Oct; 77(2):99-105. PubMed ID: 7954328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA.
    Cheng JQ; Ruggeri B; Klein WM; Sonoda G; Altomare DA; Watson DK; Testa JR
    Proc Natl Acad Sci U S A; 1996 Apr; 93(8):3636-41. PubMed ID: 8622988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin gene amplification and overexpression in breast and ovarian cancers: evidence for the selection of cyclin D1 in breast and cyclin E in ovarian tumors.
    Courjal F; Louason G; Speiser P; Katsaros D; Zeillinger R; Theillet C
    Int J Cancer; 1996 Aug; 69(4):247-53. PubMed ID: 8797862
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amplification and overexpression of the AKT2 oncogene in a subset of human pancreatic ductal adenocarcinomas.
    Ruggeri BA; Huang L; Wood M; Cheng JQ; Testa JR
    Mol Carcinog; 1998 Feb; 21(2):81-6. PubMed ID: 9496907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of c-myc oncogene amplification and chromosomal anomalies in metastatic prostatic carcinoma by fluorescence in situ hybridization.
    Jenkins RB; Qian J; Lieber MM; Bostwick DG
    Cancer Res; 1997 Feb; 57(3):524-31. PubMed ID: 9012485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics and ovarian carcinoma.
    Lynch HT; Casey MJ; Lynch J; White TE; Godwin AK
    Semin Oncol; 1998 Jun; 25(3):265-80. PubMed ID: 9633840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer.
    Tanner MM; Grenman S; Koul A; Johannsson O; Meltzer P; Pejovic T; Borg A; Isola JJ
    Clin Cancer Res; 2000 May; 6(5):1833-9. PubMed ID: 10815905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of chromosomal structural alterations in human ovarian carcinoma cells using combined GTG-banding and repetitive fluorescence in situ hybridization (FISH).
    Xu J; Wang N
    Cancer Genet Cytogenet; 1994 May; 74(1):1-7. PubMed ID: 8194040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FISH analyses of a newly established thyroid tumor cell line showing a t(1;19)(p35 or p36.1;q13) reveal that the breakpoint lies between 19q13.3-13.4 and 19q13.4.
    Belge G; Garcia E; de Jong P; Bartnitzke S; Bullerdiek J
    Cytogenet Cell Genet; 1995; 69(3-4):220-2. PubMed ID: 7698017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosome imbalances and alterations of AURKA and MYCN genes in children with neuroblastoma.
    Inandiklioğlu N; Yilmaz S; Demirhan O; Erdoğan S; Tanyeli A
    Asian Pac J Cancer Prev; 2012; 13(11):5391-7. PubMed ID: 23317189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CA125 and UQCRFS1 FISH studies of ovarian carcinoma.
    Kaneko SJ; Gerasimova T; Smith ST; Lloyd KO; Suzumori K; Young SR
    Gynecol Oncol; 2003 Jul; 90(1):29-36. PubMed ID: 12821338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.